Tesla (TSLA, Financials) founder Elon Musk and a group of investors have made an unsolicited $97.4 billion bid to acquire the ...

Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.

Wedbush views the unsolicited $97.4B bid by a group led by Elon Musk for the non-profit that controls OpenAI, aimed to slow down the startup's capital raising process.

Raymond James analyst Brian Vaccaro, who reiterated a market-perform rating on McDonald's, was less bullish. He said U.S. comparable visibility remains cloudy in the near term given continued softness ...

Wedbush Securities adjusted its price target for Palo Alto Networks (NASDAQ:PANW) shares, reducing it from the previous $400.00 to $225.00, while retaining an Outperform rating for the cybersecurity ...

Palantir and Salesforce lead AI-driven software expansion, as AI spending surges and enterprise adoption accelerates ...

Wedbush said Palantir Technologies (PLTR) and Salesforce (CRM) remain the two best software plays on the AI Revolution for 2025.

Super Micro Computer (SMCI) stock gained nearly 18% yesterday, ahead of its most anticipated Q2 FY25 results. The question ...

Investment analysts at Wedbush cut their FY2025 earnings per share estimates for Advanced Micro Devices in a research report issued on Wednesday, February 5th. Wedbush analyst M. Bryson now expects ...

Wedbush decreased their Q1 2025 earnings per share estimates for shares of O’Reilly Automotive in a research note issued to investors on Thursday, February 6th. Wedbush analyst S. Basham now expects ...